ASTRAZENECA PHARMA INDIA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,182 INR | +2.98% |
|
-2.75% | +12.00% |
| May. 28 | Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4 | MT |
| May. 27 | AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.8B | - | - | - | - | - | |
| 749B | ||||||
| 605B | ||||||
| 351B | ||||||
| 328B | ||||||
| 292B |
